Moms Receive EU Orphan Drug Designation From European Medicines Agency For Novel Cholesterol Drug Called Cyclodextrin
September 14, 2011 by Chris Hempel
Filed under Featured Stories
Last year, after Dr. Caroline Hastings and I received the U.S. Food and Drug Administration orphan drug designation for Hydroxy-propyl-beta-cyclodextrin (HPBCD) for the treatment of Niemann Pick Type C disease, I was contacted by Sue French. Sue lives in the United Kingdom and her son William is also afflicted with the rare and fatal genetic […]
Procter & Gamble’s Febreze Product May Contain Active Drug Compound That Can Enter Human Cell
July 19, 2011 by Chris Hempel
Filed under Featured Stories
Something does not smell right over at Procter & Gamble. For more than a year, I have been trying to reach the proper people at the company (ie. Sr. Execs) in order to get them to pay attention to the fact that one of their key products has a potential drug in it that millions […]
Insulin Therapy and Alzheimer’s – Could Cyclodextrin Sugar Act on Insulin and Glucose Metabolism?
April 10, 2011 by Chris Hempel
Filed under Uncategorized
Recently reports in the news shows how insulin therapy may be a treatment for Alzheimer’s. Basically, a low dose of insulin has been found to suppress the expression in the blood of four precursor proteins involved in the pathogenesis of Alzheimer’s disease, according to research by University at Buffalo endocrinologists. Paresh Dandona, MD, PhD, University […]